Filed Feb 2, 2026Period of report Jan 29, 20260001760395-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 29, 2026
Ordinary SharesF1F2F3
534
$4.86
$2.60K
Bpifrance Investissement S.A.S.Member of 10% owner group
Bpifrance Participations SAMember of 10% owner group
Bpifrance SAMember of 10% owner group
Caisse DES Depots et ConsignationsMember of 10% owner group
EPIC BpifranceMember of 10% owner group
4
Filed Dec 19, 2025Period of report Dec 17, 20250001104659-25-123104
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Mohideen PharisChief Medical Officer
4
Filed Nov 25, 2025Period of report Nov 20, 20250001760395-25-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 21, 2025
Ordinary SharesF1F2F4
1,624
$2.77
$4.50K
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
144,995
Direct
Filing footnotes · 3
F1The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
F2Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F3This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1974 to EURO 1.00 as of January 29, 2026.
F1The price reported in Column 4 is a weighted average price in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1741 to EURO 1.00 as of December 17, 2025. The shares were sold in multiple transactions at prices ranging from $4.24 to $5.23 per share, inclusive. The reporting person unterakes to provide DBV Technologies S.A., any security holder of DBV Technologies S.A., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 4 of this Form 4.
F2Bpifrance Participations S.A. ("Bpifrance Participations") directly owns the reported shares. Bpifrance Participations is a subsidiary owned at 99.99% by Bpifrance S.A. ("Bpifrance"). Bpifrance is jointly owned by Caisse des Depots et Consignations ("CDC") at 49.2% and EPIC Bpifrance ("EPIC") at 49.2%. CDC and EPIC jointly control Bpifrance.
F3The price reported in Column 4 reflects the conversion of EURO to USD at an exchange rate of $1.1741 to EURO 1.00 as of December 17, 2025.
F4The price reported in Column 4 is a weighted average price in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1727 to EURO 1.00 as of December 18, 2025 . The shares were sold in multiple transactions at prices ranging from $3.79 to $4.32 per share, inclusive.
F5Innobio FPCI ("Innobio") directly owns the reported shares. Innobio is a fund managed by Bpifrance Investissement S.A.S. ("Bpifrance Investissement"), a subsidiary owned at 100% by Bpifrance Participations.
F1The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
F2Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F3This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15268 to EURO 1.00 as of November 20, 2025.
F4This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.
F5Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.
F6The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.
